Fernández ML, Vivas S, Ruiz de Morales JM, Marugán JM. Utilidad de los anticuerpos antitransglutaminasa en el diagnóstico de la enfermedad celíaca.
Gastroenterología y Hepatología 2005;
28:437-40. [PMID:
16185576 DOI:
10.1157/13078992]
[Citation(s) in RCA: 13] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/20/2023]
Abstract
BACKGROUND
Anti-transglutaminase antibodies have been proposed as a useful tool in the diagnosis and follow-up of celiac disease.
AIM
To compare anti-transglutaminase antibodies with the classical antibodies used to diagnose celiac disease.
MATERIAL AND METHOD
Patients who underwent duodenal biopsy for suspected celiac disease were selected if they had the following serum antibody samples: antiendomysial IgA, anti-transglutaminase IgA, antigliadin IgG, and antigliadin IgA. A diagnostic value of each of these antibodies was established according to the final diagnosis, taking the duodenal biopsy as the reference.
RESULTS
One hundred twenty-two patients with duodenal biopsy and serologic markers for celiac disease were selected. Thirty-six patients were children (< 14 years-old) and 86 were adults. A diagnosis of celiac disease was made in 41 patients (26 children and 15 adults). Of the 15 adults, only 2 (13%) presented typical malabsorption syndrome. The sensitivity and specificity of anti-transglutaminase antibodies was 100% and 98% respectively compared with values of 97% and 98% for antiendomysial IgA, 85% and 97% for antigliadin IgA, and 97% and 92% for antigliadin IgG antibodies.
CONCLUSIONS
The diagnostic value of anti-transglutaminase antibodies is high in celiac disease. These antibodies may be useful as a screening test to select candidates for duodenal biopsy.
Collapse